|
Forschungsdatenbank
Forschungsprojekt
|
Projektleiter:
Univ.-Prof. Dr. Julia B Hennermann
EFC14028-COMET mit Substanz GZ402666-neoGAA (Phase 3 klinische Studie)
A phase 3 randomized, multicenter, multinational, double blinded study comparing the efficacy and safety of repeated biweekly infusions of neoGAA (GZ402666) and alglucosidase alfa in treatment naive patients with late onset Pompe disease |
Laufzeit:
2018-2021
|
|
|
|